May 29, 2024 · Aspirin, a nonsteroidal anti-inflammatory drug (NSAID), is inversely associated with colorectal cancer (CRC) risk. In meta-analyses and ...
Two genome-wide interaction loci modify the association of nonsteroidal anti-inflammatory drugs with colorectal cancer. Sci Adv. 2024 May 31;10(22):eadk3121 ...
scholar.google.com › citations
May 29, 2024 · Genetic variants on chromosomes 5 and 6 modulate protective associations between regular aspirin/NSAID use and colorectal cancer. INTRODUCTION.
Two genome-wide interaction loci modify the association of nonsteroidal anti-inflammatory drugs with colorectal cancer. Science advances. Authors. David Drew.
Two genome-wide interaction loci modify the association of ...
ui.adsabs.harvard.edu › abs › abstract
Genetic variants on chromosomes 5 and 6 modulate protective associations between regular aspirin/NSAID use and colorectal cancer. Publication: Science Advances.
Dive into the research topics of 'Two genome-wide interaction loci modify the association of nonsteroidal anti-inflammatory drugs with colorectal cancer'.
May 31, 2024 · Background: Regular use of non-steroidal anti-inflammatory drugs (NSAIDs) is associated with lower risk of colorectal cancer (CRC). Genome-wide ...
May 31, 2024 · Two genome-wide interaction loci modify the association of nonsteroidal anti-inflammatory drugs with colorectal cancer. Drew, D. A. ; Kim ...
People also ask
What are the tumor suppressor genes in colorectal cancer?
How do NSAIDs prevent colon cancer?
What are the familial colorectal cancer genes mutations?
Regular, long-term aspirin use may act synergistically with genetic variants, particularly those in mechanistically relevant pathways, ...
Jul 1, 2024 · We identified two previously undescribed genetic loci that modify the protective effect of regular aspirin/NSAID use on colorectal cancer risk.